Article
Author(s):
San Francisco - The FDA has its eye on New-Fill (Dermik Laboratories), a polylactic acid filler that experts predict could become a popular treatment for moderate to deep wrinkles and volume loss.
OS-01 Peptide Product Can Reduce Signs of Periorbital Skin Aging
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Micro-Coring Revolutionized: Cytrellis' Denise Dajles, DEng, MSc, on Evolving Skin Treatments with Ellacor 2.0
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
VP-315 Demonstrates Positive Topline Results in Basal Cell Carcinoma
Study Explores Psoriasis-Dementia Link